Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA drug recalls in 2020

Every FDA drug recall initiated in 2020, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.

930 recalls, newest first.

Class II · Moderate risk

ePHEDrine Sulfate

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71030-003-09 D-1088-2020
Class II · Moderate risk

rocuronium Bromide

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71019-321-05 D-1087-2020
Class II · Moderate risk

nICARdipine HCl

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71019-206-01 D-1082-2020
Class II · Moderate risk

ePHEDrine Sulfate

Firm is recalling 46 lots of various products because of a lack of sterility assurance.

Terminated Sterility / contamination PharMEDium Services, LLC NDC 71030-003-12 D-1081-2020
Class II · Moderate risk

Advil Liqui-Gel Mini 160+20+20 CT

Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.

Terminated Labeling / mix-up Glaxosmithkline Consumer Healthcare Holdings NDC 0573-1715-59 D-1069-2020
Class II · Moderate risk

*Mitomycin 0.04% Ophth DR eye drops

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 67457-0518-05 D-1077-2020
Class II · Moderate risk

*Morphine 2 mg/mL Cassette

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 00409-1134-03 D-1075-2020
Class II · Moderate risk

C-*Vancomycin Opthal 14 mg drops

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 67457-0340-01 D-1074-2020
Class II · Moderate risk

C-*Albumin Eye Drop 10% S

Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.

Terminated Sterility / contamination Medical Center Pharmacy, Inc. NDC 44206-0251-05 D-1073-2020
Class II · Moderate risk

Doxycycline Capsules

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Terminated cGMP deviation Sun Pharmaceutical Industries, Inc. NDC 63304-616-50 D-1033-2020
Class II · Moderate risk

Doxycycline Capsules

CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.

Terminated cGMP deviation Sun Pharmaceutical Industries, Inc. NDC 63304-615-01 D-1032-2020

Recalls by year